These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 3286116)

  • 41. The roles of fibrinogen and fibrin in hemostasis and thrombosis.
    Mosesson MW
    Semin Hematol; 1992 Jul; 29(3):177-88. PubMed ID: 1641664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impaired fibrin gel permeability by high homocysteine levels.
    Quintana IL; Oberholzer MV; Kordich L; Lauricella AM
    Thromb Res; 2011 Jan; 127(1):35-8. PubMed ID: 19744701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.
    Siebenlist KR; Mosesson MW; Hernandez I; Bush LA; Di Cera E; Shainoff JR; Di Orio JP; Stojanovic L
    Blood; 2005 Oct; 106(8):2730-6. PubMed ID: 16002430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic Variants in the
    Simurda T; Brunclikova M; Asselta R; Caccia S; Zolkova J; Kolkova Z; Loderer D; Skornova I; Hudecek J; Lasabova Z; Stasko J; Kubisz P
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The conversion of fibrinogen to fibrin: A brief history of some key events.
    Doolittle RF
    Matrix Biol; 2017 Jul; 60-61():5-7. PubMed ID: 27519977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibrinogen and Factor XIII in Venous Thrombosis and Thrombus Stability.
    Wolberg AS; Sang Y
    Arterioscler Thromb Vasc Biol; 2022 Aug; 42(8):931-941. PubMed ID: 35652333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycosylation of human fibrinogen and fibrin in vitro. Its consequences on the properties of fibrin(ogen).
    Mirshahi M; Soria J; Soria C; Bertrand O; Mirshahi M; Basdevant A
    Thromb Res; 1987 Nov; 48(3):279-89. PubMed ID: 3124289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kinetic model facilitates analysis of fibrin generation and its modulation by clotting factors: implications for hemostasis-enhancing therapies.
    Mitrophanov AY; Wolberg AS; Reifman J
    Mol Biosyst; 2014 Jul; 10(9):2347-57. PubMed ID: 24958246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factor XIII: structure, activation, and interactions with fibrinogen and fibrin.
    Lorand L
    Ann N Y Acad Sci; 2001; 936():291-311. PubMed ID: 11460485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enzymatic basis for platelet aggregation and release: the significance of the 'platelet atmosphere' and the relationship between platelet function and blood coagulation.
    Ardlie NG; Han P
    Br J Haematol; 1974 Mar; 26(3):331-56. PubMed ID: 4851871
    [No Abstract]   [Full Text] [Related]  

  • 51. Fibrin: structure and interactions.
    Hermans J; McDonagh J
    Semin Thromb Hemost; 1982 Jan; 8(1):11-24. PubMed ID: 7036348
    [No Abstract]   [Full Text] [Related]  

  • 52. Babesia bovis (argentina): observations of coagulation parameters, fibrinogen catabolism and fibrinolysis in intact and splenectomized cattle.
    Goodger BV; Wright IG
    Z Parasitenkd; 1977 Dec; 54(1):9-27. PubMed ID: 602370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibrin as a factor in atherogenesis.
    Smith EB; Thompson WD
    Thromb Res; 1994 Jan; 73(1):1-19. PubMed ID: 8178309
    [No Abstract]   [Full Text] [Related]  

  • 54. Coagulation studies in patients treated with defibrase.
    Egberg N
    Acta Med Scand; 1973 Oct; 194(4):291-302. PubMed ID: 4749167
    [No Abstract]   [Full Text] [Related]  

  • 55. THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.
    STAFFORD JL
    J Clin Pathol; 1964 Sep; 17(5):520-30. PubMed ID: 14207786
    [No Abstract]   [Full Text] [Related]  

  • 56. von Willebrand factor and fibrinogen.
    Ruggeri ZM
    Curr Opin Cell Biol; 1993 Oct; 5(5):898-906. PubMed ID: 8240833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Fibrinolysis activities and factor XIII in the neonatal period. 1. Fibrinolysis activity and fibrin degradation products in the neonatal period].
    Yamada Z
    Nihon Shonika Gakkai Zasshi; 1971 Apr; 75(4):294-6. PubMed ID: 4252802
    [No Abstract]   [Full Text] [Related]  

  • 58. Degradation products of fibrinogen and fibrin in bacteremia due to gram-negative rods.
    Satterwhite TK; Hawiger J; Burklow SL; Koenig MG
    J Infect Dis; 1973 Apr; 127(4):437-41. PubMed ID: 4694546
    [No Abstract]   [Full Text] [Related]  

  • 59. Coagulation and fibrinolysis after injury.
    Flute PT
    J Clin Pathol Suppl (R Coll Pathol); 1970; 4():102-9. PubMed ID: 5293379
    [No Abstract]   [Full Text] [Related]  

  • 60. [Fibrinogen (fibrin), factor VIII and factor XIII in children with various renal disease (author's transl)].
    Kamitsuji H; Tani K; Masuyama H; Ichikawa M; Taniguchi A; Takeuchi Y; Iwagaki K
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):23-40. PubMed ID: 6770133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.